|Articles|May 17, 2021
Disruption without interruption: Transitioning Rare Disease HUB & NCP Programs
Author(s)RareMed Solutions
Transitioning a rare disease HUB or NCP program to a rare-focused partner can yield major service quality improvements without program disruption.
Advertisement
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
What the Closure of a Single Plant Reveals About US Drug Resilience
2
Knipper Health Rebrands as CareTria to Expand Integrated Therapy Initiation Platform
3
DHL Supply Chain Opens 1-Million-Square-Foot Life Sciences Distribution Center in Pennsylvania, Expanding Healthcare Logistics Footprint
4
GoodRx Offers FDA-Approved Wegovy Pill at $149 Monthly Cash Price Across US Pharmacies
5